Key facts
- This page summarizes Watsa V Prem Et al's Form 4 filing for Crescent Capital BDC, Inc. (CCAP).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Jan 2022, 20:12.
Watsa V Prem Et al - 11 Jan 2022 Form 4 Insider Report for Crescent Capital BDC, Inc. (CCAP)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- CCAP
- Reported as of
- 11 Jan 2022
- Net transaction value
- -$1,546,099
- SEC form
- 4
- Accepted by SEC
- 12 Jan 2022, 20:12:22 UTC
- Prior SEC filing
- 10 Jan 2022
- Next SEC filing
- 01 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ V. Prem Watsa
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Watsa V Prem Et al filed Form 4 for Crescent Capital BDC, Inc. (CCAP) on 12 Jan 2022.
Change
- Previous filing in this sequence was filed on 10 Jan 2022.
- Current net transaction value: -$1,546,099.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CCAP
transaction
Common Stock
Sale
- Transaction value
- $588,468
- Shares
- -32,548
- Change %
- -1%
- Price
- $18.08
- Shares after
- 3,113,354
- Date
- 11 Jan 2022
- Ownership
- See footnote
- Footnotes
- F1, F2, F4
CCAP
transaction
Common Stock
Sale
- Transaction value
- $957,632
- Shares
- -52,675
- Change %
- -1.7%
- Price
- $18.18
- Shares after
- 3,060,679
- Date
- 12 Jan 2022
- Ownership
- See footnote
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Watsa V Prem Et al is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
This transaction was executed in multiple trades at prices ranging from $18.04 to $18.14. The shares sold include 23,515 shares sold by Allied World Assurance Company, Ltd., GmbH ("Allied World") and 9,033 shares sold by Brit Reinsurance (Bermuda) Limited - FAL ("Brit"), which are both subsidiaries of Fairfax Financial Holdings Limited.
Footnote F2
The price reported reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F3
This transaction was executed in multiple trades at prices ranging from $18.14 to $18.31. The shares sold include 38,056 shares sold by Allied World and 14,619 shares sold by Brit.
Footnote F4
These securities are held by wholly-owned subsidiaries of Fairfax Financial Holdings Limited. Mr. Watsa is the CEO and controlling person of Fairfax Financial Holdings Limited through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.